Meeting
2023 ASCO Gastrointestinal Cancers Symposium
The HORIZON III retrospective exploratory analysis: HER2 expression amplification in colorectal cancer.
Authors
Fabiola Cecchi
AstraZeneca Translational Medicine, Early Oncology, Gaithersburg, MD;
Fabiola Cecchi , Natasha Viglianti , Marlon Rebelatto , Norah J Shire , Simon T Barry , Tsveta Milenkova , Elizabeth Croydon , Danielle Carroll , J Carl Barrett
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Clinical Trial Registration Number
NCT00384176
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 194)
DOI
10.1200/JCO.2023.41.4_suppl.194
Abstract #
194
Poster Bd #
K16
Abstract Disclosures
Similar Posters
Poster
2017 ASCO-SITC Clinical Immuno-Oncology Symposium
HER2 gene amplification and protein overexpression in uterine clear cell carcinoma and its implications in targeted immunotherapy.
First Author: Jain Zhou
Poster
2014 Gastrointestinal Cancers Symposium
A novel method combining gene and protein platforms on one slide for the detection of HER2 in gastric cancer: Final results.
First Author: Dominique Werner
Poster
2020 ASCO Virtual Scientific Program
Predictive and prognostic value of HER2 gene expression and HER2 amplification in patients with metastatic colorectal cancer (mCRC) enrolled in CALGB/SWOG 80405 (Alliance).
First Author: Francesca Battaglin
Poster
2015 ASCO Annual Meeting
Defining the spectrum and "overlap" of HER2 aberrations in lung cancers: Associations of HER2 protein overexpression, HER2 amplification, and HER2 mutation.
First Author: Bob T. Li